https://orcid.org/0000-0002-8316-8671
References
- Mochizuki T, Yano K, Ikari K, Okazaki K. Sarcopenia-associated factors in Japanese patients with rheumatoid arthritis: a cross-sectional study. Geriatr Gerontol Int. 2019;19(9):907–12.
- Chen LK, Liu LK, Woo J, Assantachai P, Auyeung TW, Bahyah KS, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014;15(2):95–101.
- Kimura A, Seichi A, Konno S, Yabuki S, Hayashi K. Prevalence of locomotive syndrome in Japan: a nationwide, cross-sectional Internet survey. J Orthop Sci. 2014;19(5):792–7.
- Yoshimura N, Muraki S, Nakamura K, Tanaka S. Epidemiology of the locomotive syndrome: the research on osteoarthritis/osteoporosis against disability study 2005–2015. Mod Rheumatol. 2017;27(1):1–7.
- Yoshimura N, Muraki S, Iidaka T, Oka H, Horii C, Kawaguchi H, et al. Prevalence and co-existence of locomotive syndrome, sarcopenia, and frailty: the third survey of Research on Osteoarthritis/Osteoporosis Against Disability (ROAD) study. J Bone Miner Metab. 2019;37(6):1058–66.
- Kroot EJ, de Jong BA, van Leeuwen MA, Swinkels H, van den Hoogen FH, van’t Hof M, et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum. 2000;43(8):1831–5.
- Koevoets R, Dirven L, Klarenbeek NB, van Krugten MV, Ronday HK, van der Heijde DM, et al. Insights in the relationship of joint space narrowing versus erosive joint damage and physical functioning of patients with RA. Ann Rheum Dis. 2013;72(6):870–4.
- Mochizuki T, Ikari K, Yano K, Okazaki K. Evaluation of factors associated with locomotive syndrome in Japanese elderly and younger patients with rheumatoid arthritis. Mod Rheumatol. 2019;29(5):733–6.
- Izawa N, Hirose J, Fujii T, Oka H, Uehara K, Naito M, et al. The utility of 25-question Geriatric Locomotive Function Scale for evaluating functional ability and disease activity in Japanese rheumatoid arthritis patients: a cross-sectional study using NinJa database. Mod Rheumatol. 2019;29(2):328–34.